|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| HCO | |||||
| MPN | |||||
| Medical Bill Review | |||||
| Utilization Review | |||||
| Medical Case Management | |||||
| Other | |||||
| Total revenues | |||||
| Expenses | |||||
| Depreciation and amortization | |||||
| Bad debt provision (recovery) | |||||
| Consulting fees | |||||
| Salaries and wages | |||||
| Professional fees | |||||
| Insurance | |||||
| Outsource service fees | |||||
| Data maintenance | |||||
| General and administrative | |||||
| Total expenses | |||||
| Income from operations | |||||
| Other income (expense) | |||||
| Other income (Note 14) | |||||
| Interest income | |||||
| Interest expense | |||||
| Total other income, net | |||||
| Income before taxes | |||||
| Income tax provision | |||||
| Net income | |||||
| Basic earnings per share: | |||||
| Net Income per share amount (in Dollars per share) | |||||
| Weighted average shares outstanding, basic (in Shares) | |||||
| Fully diluted earnings per share: | |||||
| Net Income per share amount (in Dollars per share) | |||||
| Weighted average shares outstanding, diluted (in Shares) | |||||
Loading...